For example, some studies measure PD-L1 expression on tumor cells alone using the Tumor Proportion Score (TPS) methodology [150], while other studies assess PD-L1 expression on both tumor and immune cells using the Combined Positivity Score (CPS) methodology [150]. This evidence concerns the gene CD274 and neoplasm.